CSL Ltd (ASX: CSL) shares are trading at $183.86 on Tuesday, down 0.88% at the time of writing.

It’s been a shocker of a year for the CSL share price.

The ASX 200 healthcare giant has lost 34.6% of its market capitalisation in the year to date.

Its share price woes really began in August after the company released its FY25 report.

CSL shares fell almost 20% to a six-year low within two days.

Investors were surprised by the scale of the company’s plans to cut costs and restructure the business, including the now delayed demerger of the Seqirus vaccines division.

There was also concern over revenue weakness in the Behring business, disappointing results from the Vifor nephrology business, bought for US$11.7 billion in 2021, and higher competition in the specialty products segment.

Other challenges, particularly in terms of research and development, have also caused issues for CSL over the past few years.

The failure of the CSL112 heart drug candidate in trials, alongside lower global vaccination rates following COVID-era vaccine mandates in many countries — including Australia, where vaccination was required for certain people to return to work — has impacted the business.

The biopharmaceutical giant cut its revenue and profit growth forecasts for FY26, and the shares hit a seven-year low of $168 in October.

We’ll find out how the company is tracking in FY26 when it releases its 1H FY26 results in February.

Here are the important dates for CSL investors in the new year.

Key dates for CSL investors in 2026

CSL will release its 1H FY26 results and announce its interim dividend on 11 February.

The ex-dividend date for the CSL dividend will be 10 March.

The record date will be 11 March and the dividend will be paid on 9 April.

CSL will announce its FY25 full-year results and final dividend on 18 August.

The ex-dividend date for the final dividend will be 9 September.

The record date will be 10 September and CSL will pay investors on 2 October.

CSL will hold its annual general meeting on 27 October.

What do the experts think of CSL shares?

Morgan Stanley has a buy rating on the ASX 200 biotech with a 12-month share price target of $256.

Jarden also has a buy rating with a price target of $283.

Citi also says buy with a price target of $225.

Morgans has a buy rating on CSL shares but reduced its share price target from $293.83 to $249.51 in October.

The broker commented:

Despite the majority of the business “tracking to plan”, FY26 cc guidance had been downgraded (2-3% at revenue and NPATA mid-points), mainly reflecting continued declines in US influenza vaccination rates, although Chinese government cost containment affecting albumin demand was also flagged.

Although it remains challenging to know when US influenza vaccination rates will stabilise, we believe the risk of a permanently lower base is being over-priced, with Seqirus and Vifor marked down, with even Behring trading below peers and well under its long-term average, which we see as unjustified.

The post Own CSL shares? Here are the key dates for 2026 appeared first on The Motley Fool Australia.

More reading

• Here’s the earnings forecast out to 2030 for CSL shares
• Top brokers name 3 ASX shares to buy next week
• Here are the 3 Australian stocks I’d tell a new investor to buy asap
• 2 big ASX 200 shares this fund manager rates as buys
• Brokers name 3 ASX shares to buy today

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The All Ordinaries Index (ASX: XAO) almost certainly won’t rocket 233% next year, but this promising ASX All Ords gold stock has been tipped to do just that.

The gold miner in question is Strickland Metals Ltd (ASX: STK), which is focused on its 100%-owned 7.4-million-ounce gold equivalent Rogozna Gold and Base Metals Project, located in Serbia.

In late morning trade on Tuesday, Strickland Metals shares are flat, trading for 18 cents apiece. This sees the share price up 100% in 2025.

And according to the team at Canaccord Genuity, the ASX All Ords gold stock could deliver even juicier returns in the months ahead.

Here’s why.

Should you buy the ASX All Ords gold stock today?

On 1 December, Strickland Metals reported on new exploratory drilling results from its emerging Kotlovi prospect, located within the Rogozna Project.

Canaccord noted that the “strong assay results” further confirm the prospect as a growing high-grade gold discovery.

“All three holes successfully intersected multiple mineralised zones, marking material advances in both grade and geometry,” Canaccord said.

The broker noted:

Kotlovi, situated only ~350m west of the 1.28Moz AuEq Medenovac deposit, continues to deliver wide, consistently mineralised intercepts that expand the known footprint and reinforce the broader district scale potential.

Canaccord is optimistic on the geology around the prospect, noting, “The diversity of host rocks and structural settings suggests a robust hydrothermal system with multiple pathways for gold deposition, analogous to the styles seen across the broader Rogozna corridor.”

And the ASX All Ords gold stock looks well-funded for ongoing exploratory drilling.

According to Canaccord:

Ongoing drilling activity at Rogozna are funded by A$41.8m in cash and liquids as at 30 September 2025. Seven rigs are currently operating, four targeting the Gradina gap zone and three focused on new discovery drilling, including further work at Kotlovi.

Investors can also look forward to fresh news from the project in the near term, which, depending on the results, could give the Strickland Metals share price a boost.

“Numerous assays remain pending, and additional updates are expected in the coming weeks, including a maiden resource over Gradina,” Canaccord said.

High risk for potentially high reward

Connecting the dots, Canaccord has a speculative buy rating on the ASX All Ords gold stock, with a 60-cent price target.

That represents a potential upside of 233.3% from current levels.

Canaccord stressed that this potentially outsized return is not without investment risk.

According to the broker:

Our valuation is risked to 50% given the model is unfunded and Gradina is pre-resource. Our scenario is preliminary in nature and should be viewed as a what-if case, given that no formal mining studies have been published.

The post Why this surging ASX All Ords gold stock is tipped to rocket another 233% appeared first on The Motley Fool Australia.

More reading

• Up 146% in a year, ASX All Ords gold stock reveals ‘significant upside’ exploration results
• Guess which ASX All Ords gold stock is leaping 12% on big Serbian news
• Why Breville, Flight Centre, Mineral Resources, and Strickland shares are shooting higher

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Wondering which ASX blue chip shares to buy or sell? Let’s take a look at what analysts are saying about three popular options, courtesy of The Bull.

Here’s what they are recommending to their clients:

Medibank Private Ltd (ASX: MPL)

Catapult Wealth is feeling bearish about private health giant Medibank and has named it as a sell.

It has concerns about rising cost pressures, which it feels have created a challenging outlook for the company. It said:

MPL is a private health insurer. The Federal Government is attempting to encourage private health insurers to increase payments to private hospitals. Net profit after tax of $500.8 million in fiscal year 2025 was up a modest 1.7 per cent on the prior corresponding period. Profit before tax of $728.8 million was up 2.4 per cent. The company was recently trading on an annual dividend yield of 3.9 per cent. The risk of increasing cost pressures paints a challenging outlook. The shares have fallen from $5.26 on August 21 to trade at $4.545 on December 4.

Qantas Airways Ltd (ASX: QAN)

The team at Sanlam Private Wealth has put a sell rating on the shares of airline operator Qantas.

It feels that its earnings growth outlook is now more modest than in previous years and its fleet investments will require significant capital. In light of this, it feels that the Flying Kangaroo’s shares are now overvalued. Sanlam Private Wealth said:

The share price has run ahead of fundamentals, making it vulnerable to any possible downgrades, in our view. We believe the outlook for earnings growth is modest compared to the recent past. Fleet renewal plans and sustainability investments require substantial capital, which could potentially mute shareholder returns moving forward. The shares have risen from $8.02 on April 9 to trade at $9.74 on December 4, so investors may want to consider cashing in some gains.

Xero Ltd (ASX: XRO)

One ASX share that Catapult Wealth is feeling positive on is Xero. It has recommended the cloud accounting platform provider as a buy.

It was impressed with its performance during the first half of FY 2026 and believes that recent share price weakness has created a buying opportunity for investors. Especially given the potential for a meaningful re-rating of its share price if the US business starts to kick into gear. It said:

XRO is a global accounting software provider. Average revenue per user was up 15 per cent in the first half of 2026 when compared to the prior corresponding period. EBITDA was up 21 per cent. Rolling out bank feed connections in the United States will be a tail wind moving forward. In our view, the recent fall in the share price reflects a short-sighted assessment of revenue and subscriber growth rates. The US payments opportunity is significant, and any signs of successful execution and acceleration in growth will drive a meaningful re-rate.

The post Buy, hold, sell: Medibank, Qantas, and Xero shares appeared first on The Motley Fool Australia.

More reading

• Stocks to target for a tech rebound in 2026
• Experts name 3 popular 200 ASX shares to sell now
• How to build a $100,000 ASX share portfolio starting at zero
• The smart way to make a $25,000 passive income from ASX shares
• 3 explosive ASX ETFs to buy and hold

Motley Fool contributor James Mickleboro has positions in Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Some of the most compelling investments to own could be ASX small-cap stocks that are undervalued by the market.

Fund manager Wilson Asset Management has outlined two businesses in the WAM Microcap Ltd (ASX: WMI) portfolio that could be good performers in the coming years.

WAM Microcap, a listed investment company (LIC), is looking for the “most exciting undervalued growth opportunities in the Australian micro-cap market”.

Let’s take a look at which small businesses WAM likes.

Stealth Group Holdings Ltd (ASX: SGI)

The fund manager described Stealth Group Holdings as a diversified, multi-channel distribution business that supplies industrial, hardware, safety and consumer products to trade and retail customers across Australia.

During November 2025, the Stealth Group Holdings share price increased sharply (up 60%) after the company announced the acquisition of Hardware & Building Traders (HBT), Australia’s largest privately-owned hardware and industrial buying group.

The acquisition significantly increased the ASX small-cap stock’s scale, expanding distribution points from 32 to more than 1,200 independent retail and trade stores in Australia, raising purchasing volume by approximately $700 million and adding around 490 suppliers in the ecosystem.

The company increased its FY28 targets to more than $500 million in sales and provided profit margin targets that imply up to $40 million in net profit after tax (NPAT). The fund manager believes these targets are “relatively conservative” in the context of the “significant synergy potential and the company’s ability to undertake further acquisitions over time, none of which are included in these targets”.

Wilson Asset Management concluded on the ASX small-cap stock:

Whilst the share price increased by more than 60% over the month as investors priced in stronger medium-term growth and returns from the enlarged platform, we continue to see substantial re-rating potential.

EML Payments Ltd (ASX: EML)

WAM described EML Payments as a global payments solutions company that powers business processes “seamlessly for growth and exceptional customer experiences”.

During the month, the EML Payments share price fell 11% after the company revealed operating trends that were weaker than expected at its annual general meeting (AGM).

The company’s FY26 first quarter update revealed a decline of underlying earnings before interest, tax, depreciation and amortisation (EBITDA) of approximately 42% year over year, as well as a small decline in revenue. But, the company did reaffirm its full-year EBITDA guidance.

WAM noted that the update was interpreted by the market as a “weak” trading result, with soft top-line momentum.

Why does the fund manager like the ASX small-cap stock, considering these headwinds? WAM said:

Led by Chief Executive Officer Anthony Hynes, we continue to have confidence in his ability to execute on the turnaround and drive a re-rating of the share price.

The EML share price is now down around 30% in the past six months, making it a lot cheaper for interested investors.

The post 2 ASX small-cap stocks this fund manager thinks are buys appeared first on The Motley Fool Australia.

More reading

• 3 little-known ASX dividend stocks to buy for income
• Why Ausgold, DroneShield, EML, and TPG shares are falling today
• This fund manager is bullish on these ASX growth shares
• The stealth success story behind this ASX small cap’s 275% share price rally

Motley Fool contributor Tristan Harrison has positions in Wam Microcap. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended EML Payments. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX mining stocks have been on fire lately, with rising global commodity prices and booming demand pushing share prices higher.

Two major companies grabbing headline attention recently are iron ore mining giant Fortescue Metals Group (ASX: FMG) and diversified base metal miner South32 Ltd (ASX: S32). Both miners have enjoyed a steep share price uptick over the past 6 months. But when it comes to 2026, it looks like only one ASX mining stock is tipped to continue climbing. 

Are Fortescue shares a buy?

At the time of writing on Tuesday morning, Fortescue shares are 0.59% higher at $22.21 a piece. Over the past 6 months, the stock has rocketed 41.7% higher and is now up 18.05% for the year to date.

The iron ore mining giant’s shares have been boosted by the recent resilience of the global iron ore price. Iron Ore fell to US$106.42 per tonne yesterday, down 0.76% from the previous day. Over the past month, Iron ore’s price has risen 2.36%, and is up 0.08% compared to the same time last year, according to trading on a contract for difference (CFD) that tracks the benchmark market for this commodity.

In its September quarter results, the miner reported that it had increased its total iron ore shipments up 4% to a new record level. Fortescue also said that for FY26, it is sticking to its guidance of 195–205Mt in total shipments, and plans to keep costs tight. 

It’s been a great year for the iron ore miner, and its share price has reaped a hefty reward. But I’m concerned that as a miner which is so reliant on the iron ore industry, any pull-pack in iron ore prices over the next 12 months could be devastating for the business.

Analysts are on the fence too. TradingView data shows the majority have a hold rating (9 out of 15) on Fortescue shares. Another 5 have a sell or strong sell rating. The average target price for the shares is $19.02, although some think it could fall to $16.20 over the next 12 months. This implies a potential downside as large as 26.9%, at the time of writing.

Are South32 shares a buy?

At the time of writing on Tuesday morning, South32 shares are down 0.15% to $3.40 each. Over the past 6 months, the stock price has climbed 12.01%, but unlike Fortescue, South32 shares are currently trading 1.73% lower than they were at the beginning of the year.

In its September quarterly report, the producer reported another strong period of operating performance. Its production highlights included a 12% increase on payable copper at Sierra Gorda, and a 33% uplift in manganese volumes. South32 has kept its FY26 production guidance unchanged across all of its operations.

Unlike Fortescue, which is heavily focused on iron ore, South32 produces essential base metals and minerals like aluminium, copper, zinc, and many others. The BHP spin-off is also focused on high-quality, low-cost assets and is transitioning towards critical metals for the energy transition. 

It’s this diversity that means the company is well positioned to benefit from rising demand and prices of a range of different metals and minerals. It also means the business is able to hedge itself against volatility in any one market. 

Analysts are bullish on the ASX mining stock too. Data shows 9 out of 14 analysts have a buy or strong buy rating on South32’s shares. The maximum target price is $3.91, which implies a potential 14.4% upside ahead for investors, at the time of writing. 

Which is the better ASX mining stock right now?

It looks clear to me that South32 shares have a much better potential for growth compared to Fortescue shares. While both have benefitted from the latest rally in global commodity pricing, South32’s diversity helps and growth plans mean it looks like a better investment opportunity for investors right now.

The post Best ASX mining stock to buy right now: Fortescue or South32? appeared first on The Motley Fool Australia.

More reading

• 7 ASX mining shares to buy for Christmas amid upgrades from Macquarie
• ASX 200 mining shares outperform as iron ore and copper prices strengthen
• Here are the top 10 ASX 200 shares today
• Major ASX 200 mining shares hit 52-week highs
• What happened with BHP, Rio Tinto and Fortescue shares in November?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 300 Index (ASX: XKO) shares are lower on Tuesday, down 0.3% to 8,551.9 points.

Here are three ASX 300 shares that have hit fresh 52-week low share prices, yet have buy ratings from the experts.

Accent Group Ltd (ASX: AX1)

This ASX 300 retail share has a market capitalisation of $565 million.

The Accent share price is 94 cents, down 1.05% on Tuesday. This is a new 52-week low.

Accent is an Australian footwear retailer that owns several popular brands.

They include The Athlete’s Foot, Hoka, HypeDC, Platypus, Vans and Skechers.

After a trading update last month, Goldman Sachs reiterated its buy rating on Accent shares.

Accent revealed a 3.7% lift in sales during the first 20 weeks of FY26. This includes wholesale sales and sales from new stores.

On a same-store basis, sales were down 0.4% on the prior corresponding period.

Goldman Sachs analyst James Leigh put a 12-month price target range of $1.20 to $1.70 on Accent shares.

This implies a potential upside of between 27% and 81% in the new year.

REA Group Ltd (ASX: REA)

This ASX 300 communications share has a market capitalisation of $26 billion.

REA owns the popular realestate.com.au property listings portal.

The REA share price is $195, up 0.6%, on Tuesday.

Last Friday, the REA share price hit a new 52-week low of $189.14.

Morgans has an accumulate rating on REA shares with a 12-month price target of $247 per share.

This implies a potential upside of 27% in the new year.

After REA’s 1Q FY26 trading update, Morgans commented:

REA’s 1Q26 trading update benefited from a strong yield outcome (+13%), which helped to offset a softer new listings environment in the period (volumes down -8% vs the pcp).

Group revenue was A$429m (+4% on pcp), with EBITDA (ex assoc.) up 5% on pcp to A$254m.

Given REA is trading on ~42x FY26F PE (MorgansE), broadly in line with its 10-year historical average, and now with >10% TSR upside to our valuation we upgrade REA to ACCUMULATE.

Suncorp Group Ltd (ASX: SUN)

This ASX 300 financial share has a market capitalisation of $18 billion.

The Suncorp share price is $16.89, down 0.4%, on Tuesday.

Last Friday, the Suncorp share price hit a fresh 52-week low of $16.63 per share.

UBS has a buy rating on Suncorp shares with a 12-month price target of $22.

This implies a potential 30% upside over the next year for this ASX 300 insurance share.

The broker lowered its earnings forecast for Suncorp recently due to several weather events creating a rise in insurance claims.

The post 3 buy-rated ASX 300 shares at 52-week lows appeared first on The Motley Fool Australia.

More reading

• Why I think this ASX small-cap stock is a bargain at 96 cents
• 3 Australian shares to buy and hold for 20 more years
• Where to from here for these 2 ASX 200 media shares
• Top ASX shares to buy right now with $1,000
• Macquarie names best and worst ASX stocks to buy in a rising interest rate environment

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has recommended Accent Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

We recently looked at three ASX 200 shares that the team at Bell Potter is bullish on and has named as top picks for December. You can read about those shares here.

Two more of the best shares to buy this month according to the broker are listed below. Here’s why it is bullish on these names:

Catapult Sports Ltd (ASX: CAT)

A new addition this month is sports technology company Catapult Sports. The broker highlights that the company recently started to consistently generate positive EBITDA and free cash flow, and believes this can continue as it capitalises on the significant under penetration of its technology in elite sport.

In addition, Bell Potter likes the company due to its strong recurring revenue, recent acquisitions, and attractive valuation. It explains:

CAT is a leading global provider of athlete-tracking and performance analytics, supported by a recurring revenue base (~94% of total revenue) and a long runway for market penetration. CAT continues to execute a simple but effective strategy, growing its installed base, retaining customers, and steadily lifting contract value through additional modules and integrated workflows. Recent acquisitions have strengthened its position in scouting and tactical analytics, improving cross-sell potential, particularly across its large football customer base, and helping shift the product suite from point solutions to a unified system.

Importantly, CAT is now consistently generating positive EBITDA and FCF, marking a clear shift in the maturity of the business and supporting greater operating leverage as subscription revenue scales. Following a recent share price pullback, the stock screens more attractively relative to its growth outlook, and we see scope for a re-rate as management sustains cash generation and continues to capitalise on the significant under penetration of wearables and analytics across elite sport.

Nick Scali Limited (ASX: NCK)

Another new addition is furniture retailer Nick Scali. It likes the ASX 200 share due to its positive growth outlook, which is being underpinned by a structural opportunity in the UK market.

Bell Potter sees a significant expansion opportunity in the UK, which it thinks could support double-digit revenue growth through to FY 2028. It also feels that the company is well-placed to benefit from recent interest rate cuts. It said:

Nick Scali (NCK) offers a strong growth profile in the small-cap consumer space, underpinned by its structural opportunity in the UK. Early traction from the initial store roll-out validates the brand’s value proposition in a less fragmented market. Our analyst sees potential for ~60 UK stores, roughly a 3x expansion on the current footprint, supporting a group revenue CAGR of 10% out to FY28 with the largest growth of ~20% coming from the newly acquired UK business. We expect to see the realisation of operating leverage as the international network scales.

In Australia, steady market share gains in the core Nick Scali brand have helped offset a still mixed macro backdrop, while continued expansion of the Plush brand provides another growth lever. NCK’s high-quality earnings model screens well relative to global home furnishing peers, with supportive demand catalysts including improving consumer sentiment and an uplift in household goods spending following rate cuts in 2025. We expect 1H earnings to benefit from favourable 2Q26 comps and expect the UK roll-out and ongoing market share gains to drive the next leg of earnings growth and support a rerate.

The post Bell Potter names more of the best ASX 200 shares to buy in December appeared first on The Motley Fool Australia.

More reading

• These ASX 200 shares could rise 30% to 40% in 2026
• Here are the top 10 ASX 200 shares today
• Buy, hold, sell: Catapult, Step One, WiseTech Global shares
• Why Catapult, Collins Foods, Guzman Y Gomez, and Pantoro shares are falling today
• Brokers name 3 ASX shares to buy today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Catapult Sports. The Motley Fool Australia has positions in and has recommended Catapult Sports. The Motley Fool Australia has recommended Nick Scali. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Vanguard Diversified High Growth Index ETF (ASX: VDHG) is trading at $73.66 per unit, down 0.24% on Tuesday.

This ASX exchange-traded fund (ETF) is all about growth, and it’s a bit unusual in how it invests its funds.

Instead of seeking to track the performance of single index, like most ETFs do, it invests in scores of other ETFs.

This compounds the number of stocks that it’s exposed to. In the end, it’s actually invested in more than 16,000 shares.

Talk about diversification!

Some investors may feel this is too much diversification, while others may feel this lowers the risk.

The VDHG ETF has a strategic allocation of 90% growth assets, such as shares, and 10% defensives, such as bonds.

Vanguard explains the ETF’s purpose:

The ETF provides low-cost access to a range of sector funds, offering broad diversification across multiple asset classes.

The ETF invests mainly into growth assets, and is designed for investors with a high tolerance for risk who are seeking long-term capital growth.

VDHG ETF’s make up is 36% ASX shares, 26.5% unhedged international shares, 16% hedged overseas shares, 7% international fixed interest (hedged), 6.5% international small companies, 5% emerging markets, and 3% Aussie fixed interest.

There’s a management fee of 0.27% per year.

So, if you invested $10,000 in the VDHG ETF five years ago, where would your investment be today?

Let’s do the maths…

$10,000 in VDHG ETF 5 years ago…

On 9 December 2020, the VDHG ETF closed at $57.98 apiece.

If you had put $10,000 into VDHG then, it would have bought you 172 units (for $9,972.56).

There’s been a capital gain of $15.68 per unit since that time. This equates to $2,696.96 in dollar terms.

Thus, your VDHG holding is now worth $12,669.52.

Although this ETF is focused on growth, it still pays distributions (or dividends) every quarter.

Since 9 December 2020, VDHG has paid distributions of just over 1,439 cents per unit.

So, you’ve also received $2,475.08 in income over the past five years.

In this example, we’ve assumed you took your dividends as cash.

But the VDHG does have a dividend reinvestment plan (DRP) if you prefer to keep reinvesting your dividends in more stock.

Total annual returns…

Your capital gain of $12,669.52 plus $2,475.08 in dividends gives you a total dollar return of $15,144.60 over the past five years.

As stated earlier, you invested $9,972.56 buying your 172 VDHG ETF units in 2020.

This means you have received a total return, in percentage terms, of just over 51%, or an average annual return of 10.4%.

This fits with VDHG’s long-term pattern.

Since its inception date on 20 November 2017, the ETF has produced a gross average annual total return of 10.1%, or 9.8% after fees.

The post $10,000 invested in VDHG ETF 5 years ago is now worth… appeared first on The Motley Fool Australia.

More reading

• $10,000 invested in VDHG ETF 3 years ago is now worth…

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Bapcor Ltd (ASX: BAP) share price is in free fall today.

Shares in the beleaguered S&P/ASX 200 Index (ASX: XJO) auto parts company closed yesterday trading for $2.35. In morning trade on Tuesday, shares are changing hands for $1.91 each, down 18.7%.

For some context, the ASX 200 is down 0.3% at this same time.

Here’s what’s got investors reaching for their sell buttons.

Bapcor share price tanks on lower guidance

The Bapcor share price is under heavy pressure today after the company released updated guidance for the first half of FY 2026 as well as for the full FY 2026 year. And as you can guess by the market’s reaction today, the revised guidance was to the downside.

The company said that its trading performance in October and November was “below expectation”.

Bapcor’s Trade segment was a particular drag on performance. Management said that revenue fell year on year in tools and equipment, noting that parts revenue managed to grow “modestly”.

Part of the headwinds hitting the Bapcor share price arise as the company’s Trade business has been investing in pricing across specific parts categories to regain Bapcor’s market share. The company noted that these price reductions have crimped profit margins in the short term, while they are expected to drive volume growth in the future.

With the weaker-than-expected trading performance in October and November in mind, Bapcor said it now expects statutory net profit after tax (NPAT) for 1H FY 2026 to be a loss in the range of $5 million to $8 million.

Bapcor expects underlying NPAT for 1H26 (before one-off/non-recurring items) to be in the range of $5 million to $8 million.

As for the full 2026 financial year, the company now expects statutory NPAT to be in the range of $31 million to $36 million. That excludes the potential 1H26 impairment associated with the company’s New Zealand segment.

The company expects underlying NPAT for FY 2026 (before the anticipated 1H26 one-off/non-recurring items) to be in the range of $44 million to $49 million.

What did management say?

Commenting on the performance update that’s pressuring the Bapcor share price today, CEO Angus McKay said, “The weaker operational performance in October and November is disappointing.”

Looking ahead, McKay added:

Although, the turnaround of the business is more challenging and taking longer than expected we are committed to doing the difficult work that will result in a stronger, more sustainable company.

I am excited by the appointment of Craig Magill and Dean Austin to key EGM roles in the Trade and Retail segments respectively. Craig has significant Bapcor and automotive experience and Dean brings extensive retailing and merchandising experience.

With today’s intraday losses factored in, the Bapcor share price is down a painful 58.7% in 2025.

The post Why is the Bapcor share price crashing 19% on Tuesday? appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Corporate Travel Management and Boss Energy shares dumped from ASX 200
• 5 things to watch on the ASX 200 on Monday
• Macquarie names best and worst ASX stocks to buy in a rising interest rate environment

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.